Chia Tai Enterprises International Limited (3839.HK)
HKD 1.64
(0.0%)
HKD 1.64
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 33.76 Million USD | 11.66% |
| 2022 | 33.27 Million USD | 16.64% |
| 2021 | 28.53 Million USD | 28.82% |
| 2020 | 22.14 Million USD | -7.36% |
| 2019 | 23.9 Million USD | 2.41% |
| 2018 | 23.34 Million USD | 12.81% |
| 2017 | 20.69 Million USD | -12.64% |
| 2016 | 23.68 Million USD | -0.38% |
| 2015 | 23.77 Million USD | -19.54% |
| 2014 | 29.55 Million USD | 3151.05% |
| 2013 | 908.99 Thousand USD | -86.3% |
| 2012 | 6.63 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 6.02 Million USD | -34.54% |
| 2024 Q2 | 9.07 Million USD | 50.56% |
| 2023 Q2 | 8.06 Million USD | 8.45% |
| 2023 Q4 | 9.2 Million USD | 1.09% |
| 2023 FY | 37.15 Million USD | 11.66% |
| 2023 Q3 | 9.1 Million USD | 12.92% |
| 2023 Q1 | 7.43 Million USD | 5.6% |
| 2022 FY | 33.27 Million USD | 16.64% |
| 2022 Q3 | 9.5 Million USD | -14.81% |
| 2022 Q4 | 7.04 Million USD | -25.88% |
| 2022 Q1 | 10.5 Million USD | 56.31% |
| 2022 Q2 | 11.15 Million USD | 6.2% |
| 2021 Q1 | 2.3 Million USD | -34.26% |
| 2021 FY | 28.53 Million USD | 28.82% |
| 2021 Q4 | 6.71 Million USD | -40.84% |
| 2021 Q3 | 11.35 Million USD | 118.62% |
| 2021 Q2 | 5.19 Million USD | 125.24% |
| 2020 Q2 | 2.7 Million USD | 16.66% |
| 2020 Q4 | 3.5 Million USD | 19.36% |
| 2020 Q3 | 2.93 Million USD | 8.45% |
| 2020 FY | 22.14 Million USD | -7.36% |
| 2020 Q1 | 2.32 Million USD | -53.85% |
| 2019 Q2 | 889.99 Thousand USD | 10.42% |
| 2019 Q1 | 805.99 Thousand USD | -85.53% |
| 2019 FY | 23.9 Million USD | 2.41% |
| 2019 Q4 | 5.03 Million USD | 70.18% |
| 2019 Q3 | 2.95 Million USD | 232.36% |
| 2018 Q4 | 5.57 Million USD | 1963.33% |
| 2018 Q2 | 454 Thousand USD | -81.19% |
| 2018 Q1 | 2.41 Million USD | 1150.78% |
| 2018 FY | 23.34 Million USD | 12.81% |
| 2018 Q3 | 270 Thousand USD | -40.53% |
| 2017 Q4 | 192.99 Thousand USD | 89.21% |
| 2017 Q2 | 1.04 Million USD | -43.09% |
| 2017 Q1 | 1.83 Million USD | -62.9% |
| 2017 FY | 20.69 Million USD | -12.64% |
| 2017 Q3 | 102 Thousand USD | -90.21% |
| 2016 Q3 | 4.54 Million USD | 1.61% |
| 2016 Q2 | 4.46 Million USD | 37.47% |
| 2016 Q1 | 3.25 Million USD | -52.42% |
| 2016 Q4 | 4.93 Million USD | 8.68% |
| 2016 FY | 23.68 Million USD | -0.38% |
| 2015 FY | 23.77 Million USD | -19.54% |
| 2015 Q4 | 6.83 Million USD | 36.07% |
| 2015 Q3 | 5.02 Million USD | 5.37% |
| 2015 Q2 | 4.76 Million USD | 31.7% |
| 2015 Q1 | 3.61 Million USD | -49.0% |
| 2014 Q4 | 7.09 Million USD | -2.97% |
| 2014 Q3 | 7.31 Million USD | 548.14% |
| 2014 Q2 | 1.12 Million USD | 0.0% |
| 2014 Q1 | 1.12 Million USD | 0.0% |
| 2014 FY | 29.55 Million USD | 3151.05% |
| 2013 FY | 908.99 Thousand USD | -86.3% |
| 2012 FY | 6.63 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 24.42 Million HKD | -38.249% |
| Grand Pharmaceutical Group Limited | 3.86 Billion HKD | 99.125% |
| Extrawell Pharmaceutical Holdings Limited | 35.52 Million HKD | 4.957% |
| Wai Yuen Tong Medicine Holdings Limited | 353.93 Million HKD | 90.46% |
| Qianhai Health Holdings Limited | 17.1 Million HKD | -97.439% |
| Lee's Pharmaceutical Holdings Limited | 590.99 Million HKD | 94.287% |
| Essex Bio-Technology Limited | 1.22 Billion HKD | 97.252% |
| Tongfang Kontafarma Holdings Limited | 503.46 Million HKD | 93.293% |
| PuraPharm Corporation Limited | 216.62 Million HKD | 84.413% |
| SSY Group Limited | 1.98 Billion HKD | 98.295% |
| JBM (Healthcare) Limited | 163.87 Million HKD | 79.395% |
| Jacobson Pharma Corporation Limited | 287.34 Million HKD | 88.249% |
| China Resources Pharmaceutical Group Limited | 29.35 Billion HKD | 99.885% |